| Year |
Citation |
Score |
| 2024 |
Lin Q, Serratore A, Niu J, Shen S, Roy Chaudhuri T, Ma WW, Qu J, Kandel ES, Straubinger RM. Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 73: 101064. PMID 38387284 DOI: 10.1016/j.drup.2024.101064 |
0.573 |
|
| 2024 |
Roy Chaudhuri T, Lin Q, Stachowiak EK, Rosario SR, Spernyak JA, Ma WW, Stachowiak MK, Greene MK, Quinn GP, McDade SS, Clynes M, Scott CJ, Straubinger RM. Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38270582 DOI: 10.1158/1078-0432.CCR-23-0131 |
0.569 |
|
| 2023 |
Lin Q, Serratore A, Perri J, Chaudhuri TR, Qu J, Ma WW, Kandel E, Straubinger RM. FGFR1 expression correlates inversely with the efficacy of single-agent FGFR-specific inhibitors in pancreatic cancer. British Journal of Pharmacology. PMID 37994108 DOI: 10.1111/bph.16289 |
0.673 |
|
| 2023 |
Rasam S, Lin Q, Shen S, Straubinger RM, Qu J. Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis Pathway. Journal of Proteome Research. PMID 37906173 DOI: 10.1021/acs.jproteome.3c00463 |
0.685 |
|
| 2022 |
Lin Q, Shen S, Qian Z, Rasam SS, Serratore A, Jusko WJ, Kandel ES, Qu J, Straubinger RM. Comparative proteomic analysis identifies key metabolic regulators of gemcitabine resistance in pancreatic cancer. Molecular & Cellular Proteomics : McP. 100409. PMID 36084875 DOI: 10.1016/j.mcpro.2022.100409 |
0.675 |
|
| 2021 |
Lin Q, Qian Z, Jusko WJ, Mager DE, Ma WW, Straubinger RM. Synergistic pharmacodynamic effects of gemcitabine and fibroblast growth factor receptor inhibitors on pancreatic cancer cell cycle kinetics and proliferation. The Journal of Pharmacology and Experimental Therapeutics. PMID 33753538 DOI: 10.1124/jpet.120.000412 |
0.652 |
|
| 2020 |
Lin Q, He Y, Wang X, Zhang Y, Hu M, Guo W, He Y, Zhang T, Lai L, Sun Z, Yi Z, Liu M, Chen Y. Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 7: 1903483. PMID 32382484 DOI: 10.1002/Advs.201903483 |
0.45 |
|
| Show low-probability matches. |